A Study of Tocilizumab in Chinese Participants With Systemic Juvenile Idiopathic Arthritis (sJIA)
Clinical trial NCT03301883 · COMPLETED
Trial details
- NCT number
- NCT03301883
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-26
- Primary completion
- 2021-09-04
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.